Question

The true statement among the following is___

• A. The dose of telmisartan should be reduced in renal failure but not in hepatic failure.
• B. The dose of irbesartan should be reduced in case of mild-moderate hepatic failure and renalfailure.
• C. The dose of candesartan should be reduced in mild-moderate liver failure but not in renalfailure.
• D. Losartan acts as a thromboxane A2 antagonist and inhibits platelate aggregation

Answer 1

The Correct Option is D

The correct option is (D):Losartan acts as a thromboxane A2 antagonist and inhibits platelate aggregation